PDCD1LG2 and cancer: However, the absence of PD-L2 in the tumor microenvironment leads to CD8+ T cell-mediated attack on senescent cells while preventing the recruitment of myeloid-derived suppressor cancer cells, thereby enhancing the susceptibility of tumors to immune surveillance [99].